Working at Reaction Biology |

Reaction Biology Overview

Malvern, PA (US)
51 to 200 employees
Company - Private
Biotech & Pharmaceuticals
£10 to £25 million (GBP) per year


Reaction Biology Corp. (“RBC”) is a premier service provider for drug profiling, screening and early-stage drug discovery collaborations. Its proprietary HotSpot technology is an innovative platform for screening/profiling small molecules vs biological ... Read more

Reaction Biology Reviews

  • "Do not recommend"

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Current Employee - Associate Scientist III in Malvern, PA (US)
    Current Employee - Associate Scientist III in Malvern, PA (US)
    Doesn't Recommend
    Negative Outlook

    I have been working at Reaction Biology full-time (Less than a year)


    easy work, good benefits, laid back environment


    Poor management, low salary, zero room for career advancement

See All 15 Reviews

Reaction Biology Photos

Reaction Biology photo of: Discovery On Target
Reaction Biology photo of: Party celebrating 15 years
Reaction Biology photo of: Congrats Kurumi 15 years with RBC
Reaction Biology photo of: SLAS Europe 2018 Brussels, Belgium June 26-29
Reaction Biology photo of: Kelvin Lam At Conference ASCB/EMBO
Reaction Biology photo of: RBC at ASCB/EMBO Conference 2017
See All PhotosSee All

Reaction Biology Interviews



Getting an Interview

Getting an Interview





    Research Associate Interview

    Anonymous Employee
    Accepted Offer
    Positive Experience
    Average Interview


    I applied online. The process took 4+ weeks. I interviewed at Reaction Biology.


    phone interview then in-person interview. phone interview was just basic questions then for in person i met with two hr people and then that was followed by 4 people from the team.

    Interview Questions

    • why do you want to work here?   1 Answer
See All 8 Interviews

Company Updates

  • Reaction Biology will be at the following conferences​. SLAS Europe 2019, 6/26-6/28, Barcelona Discovery on Target, 9/16-9/19, Boston ELRIG Drug Discovery, 11/5-11/6, Liverpool SLAS 2020, 1/25-1/29, San Diego Drug Discovery Chemistry, 4/8-4/12, San Diego AACR 2020, 4/24-4/29, San Diego

  • PRESS RELEASE Reaction Biology Corporation Purchases ProQinase GmbH; ChinaEquity Group to become major RBC shareholder Monday, February 4, 2019 – Malvern, PA and Beijing, China – Reaction Biology Corporation ( (“RBC”) and ChinaEquity Group ( (“CEG”) announced today the completion of a stock swap transaction whereby RBC has acquired all the shares of ProQinase GmbH, an early stage drug-discovery company based in Freiburg, Germany. Founded in 2001, ProQinase specializes in kinase-based drug discovery, and in 2018 provided a full suite of biochemical and cell-based assays to over 230 customers worldwide. In addition, ProQinase has a large and growing offering of in vivo assay services, including 70 tumor models as well as immuno-oncology platforms with proprietary mouse models. In 2019, ProQinase will be moving into a newly constructed state-of-the art lab facility from which to grow further.



See AllSee All

Reaction Biology Awards & Accolades

  • Highest Ranked in Kinase Profiling Trends,, 2013

Work at Reaction Biology? Share Your Experiences

Reaction Biology
  • Star
  • Star
  • Star
  • Star
  • Star
Click to Rate